Clincosm LogoSign in Get a demo

chronic myelogenous leukemia

Showing NaN - NaN of 15
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Biphenotypic Acute Leukemia Trial in Minneapolis (biological, drug,

Not yet recruiting
  • Acute Myelogenous Leukemia
  • +17 more
  • Peripheral Blood Stem Cell Transplant
  • +7 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Mar 27, 2023

Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Minneapolis (HSCT with TBI Regimen, HSCT with

Recruiting
  • Acute Leukemia
  • +27 more
  • HSCT with TBI Regimen
  • HSCT with Non-TBI Regimen
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Apr 12, 2022

Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia/Lymphoma Trial in Minneapolis (drug, radiation, biological)

Recruiting
  • Acute Leukemia
  • +24 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Nov 4, 2021

Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Australia, Canada, United States

Completed
Has Results
  • Acute Myelogenous Leukemia
  • +4 more
  • Single Umbilical Cord Blood Unit Transplant
  • +6 more
  • Birmingham, Alabama
  • +37 more
Oct 13, 2021

Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Minneapolis (drug, radiation,

Recruiting
  • Acute Myelogenous Leukemia
  • +17 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
May 21, 2021

Acute Myelocytic Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Minneapolis (HSC835)

Completed
Has Results
  • Acute Myelocytic Leukemia
  • +12 more
  • HSC835
  • Minneapolis, Minnesota
    Novartis Investigative Site
Dec 9, 2020

Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Natural Killer Cell Malignancies Trial in Minneapolis (Infusion of Treg)

Terminated
Has Results
  • Acute Lymphoblastic Leukemia
  • +17 more
  • Infusion of Treg
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Sep 8, 2020

Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Minneapolis, Seattle (biological,

Completed
Has Results
  • Acute Myeloid Leukemia
  • +12 more
  • filgrastim
  • +6 more
  • Minneapolis, Minnesota
  • +1 more
Sep 9, 2020

Related Donors Donating PBSC to a Family Member, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in United States

Completed
  • Related Donors Donating PBSC to a Family Member
  • +7 more
  • Tampa, Florida
  • +11 more
Sep 3, 2020

Acute Leukemias, Burkitt's Lymphoma, Chronic Myelogenous Leukemia Trial in Minneapolis (drug, radiation, biological)

Terminated
Has Results
  • Acute Leukemias
  • +2 more
  • Minneapolis, Minnesota
    University of Minnesota Masonic Cancer Center
Dec 12, 2019

Acute Leukemia, Chronic Myelogenous Leukemia, Myelodysplasia Trial in United States (Tacrolimus (ARM with Methotrexate),

Completed
Has Results
  • Acute Leukemia
  • +8 more
  • Tacrolimus (ARM with Methotrexate)
  • +7 more
  • Duarte, California
  • +29 more
Jan 2, 2019

Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Minneapolis (iTreg)

Completed
  • Acute Myelogenous Leukemia
  • +7 more
  • iTreg
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Jan 17, 2019

Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia Trial in Minneapolis (90Y-AHN-12)

Terminated
  • Acute Myelogenous Leukemia
  • +3 more
  • 90Y-AHN-12
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Dec 3, 2017

Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Minneapolis (Unmanipulated UCB, SR-1

Withdrawn
  • Acute Myeloid Leukemia
  • +3 more
  • Unmanipulated UCB
  • SR-1 UCB
  • Minneapolis, Minnesota
    University of Minnesota Cancer Center
Dec 3, 2017

Chronic Myelogenous Leukemia Trial in Worldwide (imatinib mesilate, interferon-alpha (INF-a), cytarabine (ARA-C))

Completed
Has Results
  • Chronic Myelogenous Leukemia
  • imatinib mesilate
  • +2 more
  • Birmingham, Alabama
  • +162 more
Aug 7, 2013